<DOC>
	<DOCNO>NCT02559570</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy linaclotide treatment functional constipation ( FC ) , child age 6-17 year This study include 4-week Screening Period , 2 3-week Pretreatment Period . Patients age 6-11 receive oral liquid formulation patient 12-17 receive solid oral capsule liquid oral solution . Children age 6-11 year meet entry criterion randomize 1 3 dos linaclotide placebo 4 week . Children age 12-17 year meet entry criterion randomize 1 4 dos linaclotide placebo 4 week . This 4-week study ass effect linaclotide bowel movement frequency , well bowel symptom FC .</brief_summary>
	<brief_title>A Safety Efficacy Study Range Linaclotide Doses Administered Orally Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria Child/Adolescent Functional Constipation ( FC )</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<criteria>Patient weigh least 18 kg ( 39.7 lb ) Patient meet modify Rome III criterion child/adolescent FC : For least 2 month Screening Visit , patient 2 few defecation ( defecation occur absence laxative , suppository , enema use precede 24 hour ) toilet per week In addition , least per week , patient meet 1 follow : 1 . History retentive posturing excessive volitional stool retention 2 . History painful hard bowel movement ( BMs ) 3 . Presence large fecal mass rectum 4 . History large diameter stool may obstruct toilet Patient willing discontinue laxative use Pretreatment Visit favor protocolpermitted rescue medicine Patient average few 3 spontaneous BMs ( SBMs ) per week 14 day randomization day randomization . An SBM define BM occur absence laxative , enema , suppository use calendar day BM calendar day BM Patient parent/guardian/LAR caregiver compliant eDiary complete morning evening assessment 10 14 day immediately precede Randomization Visit Patient meet Rome III criterion Child/Adolescent irritable bowel syndrome ( IBS ) : At least per week least 2 month Screening Visit , patient experience abdominal discomfort ( uncomfortable sensation describe pain ) pain associate 2 follow least 25 % time : 1 . Improvement defecation 2 . Onset associate change frequency stool 3 . Onset associate change form ( appearance ) stool Patient report 1 loose , mushy stool ( eDiaryrecorded stool consistency 6 Pediatric Bristol Stool Form Scale [ pBSFS ] ) watery stool ( eDiaryrecorded stool consistency 7 pBSFS ) SBM occur absence laxative use calendar day BM calendar day BM 14 day randomization day randomization Select medical history condition may relate cause constipation may interfere safety efficacy analyse Patient require manual hospitalbased disimpaction time prior randomization Patient unable tolerate placebo Screening Period</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Functional constipation child</keyword>
	<keyword>Linzess</keyword>
</DOC>